Pulse lineResearch With Heart Logo

Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV.

TitleIncreased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV.
Publication TypeJournal Article
Year of Publication2022
AuthorsBick AG, Popadin K, Thorball CW, Uddin MMesbah, Zanni MV, Yu B, Cavassini M, Rauch A, Tarr P, Schmid P, Bernasconi E, Günthard HF, Libby P, Boerwinkle E, McLaren PJ, Ballantyne CM, Grinspoon S, Natarajan P, Fellay J
Corporate AuthorsSwiss HIV Cohort Study
JournalSci Rep
Volume12
Issue1
Pagination577
Date Published2022 01 12
ISSN2045-2322
KeywordsAdult, Case-Control Studies, Clonal Hematopoiesis, Female, HIV Infections, Humans, Male, Middle Aged, Prospective Studies
Abstract

People living with human immunodeficiency virus (PLWH) have significantly increased risk for cardiovascular disease in part due to inflammation and immune dysregulation. Clonal hematopoiesis of indeterminate potential (CHIP), the age-related acquisition and expansion of hematopoietic stem cells due to leukemogenic driver mutations, increases risk for both hematologic malignancy and coronary artery disease (CAD). Since increased inflammation is hypothesized to be both a cause and consequence of CHIP, we hypothesized that PLWH have a greater prevalence of CHIP. We searched for CHIP in multi-ethnic cases from the Swiss HIV Cohort Study (SHCS, n = 600) and controls from the Atherosclerosis Risk in the Communities study (ARIC, n = 8111) from blood DNA-derived exome sequences. We observed that HIV is associated with a twofold increase in CHIP prevalence, both in the whole study population and in a subset of 230 cases and 1002 matched controls selected by propensity matching to control for demographic imbalances (SHCS 7%, ARIC 3%, p = 0.005). We also observed that ASXL1 is the most commonly mutated CHIP-associated gene in PLWH. Our results suggest that CHIP may contribute to the excess cardiovascular risk observed in PLWH.

DOI10.1038/s41598-021-04308-2
Alternate JournalSci Rep
PubMed ID35022435
PubMed Central IDPMC8755790
Grant ListR01 HL148565 / HL / NHLBI NIH HHS / United States
HHSN268201700001I / HL / NHLBI NIH HHS / United States
HHSN268201700004I / HL / NHLBI NIH HHS / United States
P30 DK040561 / DK / NIDDK NIH HHS / United States
U01 HL123336 / HL / NHLBI NIH HHS / United States
HHSN268201700002I / HL / NHLBI NIH HHS / United States
HHSN268201700005I / HL / NHLBI NIH HHS / United States
R01 HL151283 / HL / NHLBI NIH HHS / United States
R01 HL148050 / HL / NHLBI NIH HHS / United States
DP5 OD029586 / OD / NIH HHS / United States
R01 HL086694 / HL / NHLBI NIH HHS / United States
U54 HG003273 / HG / NHGRI NIH HHS / United States
HHSN268201700003I / HL / NHLBI NIH HHS / United States